Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Targeted AntiBiotics for Chronic pulmonary diseases (TARGET ABC): can targeted antibiotic therapy improve the prognosis of Pseudomonas aeruginosa-infected patients with chronic pulmonary obstructive disease, non-cystic fibrosis bronchiectasis, and asthma? A multicenter, randomized, controlled, open-label trial.
Eklöf J, Alispahic IA, Sivapalan P, Wilcke T, Seersholm N, Armbruster K, Kjærgaard JL, Saeed MI, Nielsen TL, Browatzki A, Overgaard RH, Fenlev CS, Harboe ZB, Andreassen HF, Lapperre TS, Pedersen L, Johnsen S, Ulrik CS, Janner J, Moberg M, Heidemann M, Weinreich UM, Vijdea R, Linde H, Titlestad I, Johansson SL, Rosenvinge FS, Østergaard C, Ghathian KSA, Gundersen L, Christensen CW, Bangsborg J, Jensen TT, Sørensen VM, Ellingsgaard T, Datcu R, Coia JE, Bodtger U, Jensen JUS. Eklöf J, et al. Among authors: andreassen hf. Trials. 2022 Sep 27;23(1):817. doi: 10.1186/s13063-022-06720-z. Trials. 2022. PMID: 36167555 Free PMC article. Clinical Trial.
Eosinophil-guided corticosteroid therapy in patients admitted to hospital with COPD exacerbation (CORTICO-COP): a multicentre, randomised, controlled, open-label, non-inferiority trial.
Sivapalan P, Lapperre TS, Janner J, Laub RR, Moberg M, Bech CS, Eklöf J, Holm FS, Armbruster K, Sivapalan P, Mosbech C, Ali AKM, Seersholm N, Wilcke JT, Brøndum E, Sonne TP, Rønholt F, Andreassen HF, Ulrik CS, Vestbo J, Jensen JS. Sivapalan P, et al. Among authors: andreassen hf. Lancet Respir Med. 2019 Aug;7(8):699-709. doi: 10.1016/S2213-2600(19)30176-6. Epub 2019 May 20. Lancet Respir Med. 2019. PMID: 31122894 Clinical Trial.
Persistence and genetic adaptation of Pseudomonas aeruginosa in patients with chronic obstructive pulmonary disease.
Eklöf J, Misiakou MA, Sivapalan P, Armbruster K, Browatzki A, Nielsen TL, Lapperre TS, Andreassen HF, Janner J, Ulrik CS, Gabrielaite M, Johansen HK, Jensen A, Nielsen TV, Hertz FB, Ghathian K, Calum H, Wilcke T, Seersholm N, Jensen JS, Marvig RL. Eklöf J, et al. Among authors: andreassen hf. Clin Microbiol Infect. 2022 Jul;28(7):990-995. doi: 10.1016/j.cmi.2022.01.017. Epub 2022 Feb 3. Clin Microbiol Infect. 2022. PMID: 35124256 Free article. Clinical Trial.
A multi-center randomized, controlled, open-label trial evaluating the effects of eosinophil-guided corticosteroid-sparing therapy in hospitalised patients with COPD exacerbations - The CORTICO steroid reduction in COPD (CORTICO-COP) study protocol.
Sivapalan P, Moberg M, Eklöf J, Janner J, Vestbo J, Laub RR, Browatzki A, Armbruster K, Wilcke JT, Seersholm N, Weinreich UM, Titlestad IL, Andreassen HF, Ulrik CS, Bødtger U, Nielsen TL, Hansen EF, Jensen JUS. Sivapalan P, et al. Among authors: andreassen hf. BMC Pulm Med. 2017 Aug 15;17(1):114. doi: 10.1186/s12890-017-0458-7. BMC Pulm Med. 2017. PMID: 28810909 Free PMC article. Clinical Trial.
Bone turnover biomarkers in COPD patients randomized to either a regular or shortened course of corticosteroids: a substudy of the randomized controlled CORTICO-COP trial.
Sivapalan P, Jørgensen NR, Mathioudakis AG, Eklöf J, Lapperre T, Ulrik CS, Andreassen HF, Armbruster K, Sivapalan P, Janner J, Godtfredsen N, Weinreich UM, Nielsen TL, Seersholm N, Wilcke T, Schuetz P, Klausen TW, Marså K, Vestbo J, Jensen JU. Sivapalan P, et al. Among authors: andreassen hf. Respir Res. 2020 Oct 12;21(1):263. doi: 10.1186/s12931-020-01531-9. Respir Res. 2020. PMID: 33046053 Free PMC article. Clinical Trial.
12-months follow-up of pulmonary tele-rehabilitation versus standard pulmonary rehabilitation: A multicentre randomised clinical trial in patients with severe COPD.
Godtfredsen N, Frølich A, Bieler T, Beyer N, Kallemose T, Wilcke T, Østergaard L, Andreassen HF, Martinez G, Lavesen M, Hansen H. Godtfredsen N, et al. Among authors: andreassen hf. Respir Med. 2020 Oct;172:106129. doi: 10.1016/j.rmed.2020.106129. Epub 2020 Aug 28. Respir Med. 2020. PMID: 32905893 Free article. Clinical Trial.
Descriptive analysis of long COVID sequelae identified in a multidisciplinary clinic serving hospitalised and non-hospitalised patients.
Johnsen S, Sattler SM, Miskowiak KW, Kunalan K, Victor A, Pedersen L, Andreassen HF, Jørgensen BJ, Heebøll H, Andersen MB, Marner L, Hædersdal C, Hansen H, Ditlev SB, Porsbjerg C, Lapperre TS. Johnsen S, et al. Among authors: andreassen hf. ERJ Open Res. 2021 Aug 2;7(3):00205-2021. doi: 10.1183/23120541.00205-2021. eCollection 2021 Jul. ERJ Open Res. 2021. PMID: 34345629 Free PMC article.
Point-of-care procalcitonin test to reduce antibiotic exposure in patients hospitalized with acute exacerbation of COPD.
Corti C, Fally M, Fabricius-Bjerre A, Mortensen K, Jensen BN, Andreassen HF, Porsbjerg C, Knudsen JD, Jensen JU. Corti C, et al. Among authors: andreassen hf. Int J Chron Obstruct Pulmon Dis. 2016 Jun 22;11:1381-9. doi: 10.2147/COPD.S104051. eCollection 2016. Int J Chron Obstruct Pulmon Dis. 2016. PMID: 27382274 Free PMC article. Clinical Trial.
31 results